B cells control lupus autoimmunity by inhibiting th17 and promoting th22 cells

HIGHLIGHTS

• who: Ji Yang from the CD452+C BL/, (B6) and lupus-prone MRL/lpr mice were purchased from the Shanghai Laboratory Animal Center (Chinese Academy of Sciences). CD45.1+ mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Animal studies were approved by the Institutional Animal Care and Use Committee of Zhongshan Hospital, Fudan University. Mice were maintained under pathogen-free conditions. Twelve-week-old MRL/lpr mice were randomized into four groups, and the mice were injected intravenously with , × , ex vivoexpanded B cells or phosphate-buffered saline (PBS) control with or without, ., µg/g anti . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.